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Background: Bipolar disorder (BD) is related to reproductive cycles. However, findings
on putative correlation between age at menarche and course of BD are particularly scarce
and conflicting. The aim of the present study is to analyze the relationship between age at
menarche and characteristics of BD, including comorbid medical conditions and
peripartum mood episodes.
Methods: The study sample consists of 288 women with BD type I, II, or not otherwise
specified (NOS). Age at menarche was both considered as a continuous variable and
categorized into three groups: early menarche (≤11 years), normal menarche (12–14
years), and late menarche (≥15 years). The study focused on two sets of comparisons, by
age at menarche and women with vs. without children. Spearman correlation matrix was
produced to calculate correlations between the variables of interest. Socio-demographic
and clinical characteristics between early, normal and late menarche, and women with vs.
without children were examined through descriptive statistics. Finally, adjusted logistic
regression analysis was run to examine the association between variables.
Results:Out of 288 women included in the study, 21.5% had early menarche, 55.6% had
normal, and 22.9% had late menarche. Women with early menarche had higher rates of
metabolic syndrome compared to women with normal menarche even after adjustment
for age. The subgroup of women with children does not present clinical differences
compared to women without children except a lower rate of psychiatric comorbidities. At
least one mood episode with peripartum onset occurred in 29.6% of the women with
children. After controlling for confounding variables, women with late menarche were
associated with lower probability of BD peripartum episodes compared to women with
normal menarche.
Conclusion: Age at menarche may be related to specific characteristics of women with
BD. The results deserve to be deepened in further studies.
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Bipolar disorder (BD) is related to reproductive cycles. Women
with BD may experience mood symptoms during premenstrual,
peripartum, and perimenopausal periods. Above all, there is
strong, clear and consistent evidence of a specific correlation
between childbirth and acute episodes of BD (1). Di Florio and
colleagues reported, respectively, a 50% risk of a perinatal major
affective episode per pregnancy/postpartum period in women
with bipolar I disorder and a 40% risk in women with bipolar II
disorder (2). The risk of BD recurrences in the postpartum
period is further increased by treatment discontinuation during
pregnancy: Viguera and colleagues found that postpartum
recurrences in pregnant women with BD after lithium
discontinuation were 2.9 times more frequent than recurrences
in nonpregnant women (3); moreover, we found that the 75% of
a large sample of BD women who were medication-free during
their pregnancies experienced mood disorders after delivery (4).
While the peripartum period is clearly recognized as a high-
risk period for recurrences in patients with BD, the impact of
menstrual cycle and menopause on the course of illness is up for
debate (5–7). A cross-sectional study provided preliminary
evidences that Premestrual dysphoric disorder is frequently
comorbid with bipolar spectrum disorders, notably type II BD
and cyclothymia (8, 9). More recently, Teatero and colleagues
suggested that a subgroup of women with BD, possibly those
with hormonal sensitivity, experience menstrual cycle effects on
depressive, hypomanic, and manic episodes. These phase-
episode effects appear to be heterogeneous and may have
implications for treatment (10).
With regard to the impact of menopause on BD, results are
conflicting. It has been shown that menopause may improve,
worsen, or not affect the course of illness (11). Interestingly, it
seems that emotional disturbances during the menopausal
transition in women with BD could lead to a rapid cycling course
of the disorder (12). Moreover, data suggest that women with BD
who are not using hormone replacement therapy are more likely to
report worsening of mood symptoms during perimenopause (13).
Findings on putative correlation between age at menarche and
course of BD are particularly scarce and conflicting. Freeman and
colleagues (14) found that, in many patients, the onset of BD can
occur both before menarche and within 1 year of menarche.
Another study showed a link between age at menarche and
mood disorders suggesting that earlier menarche predicts more
depression in adolescence (15). Conversely, in a recent investigation
focused on relationship between timing of menarche, pubertal
mental health, and psychiatric disorders, the age at menarche was
significantly higher in bipolar group than schizophrenic, depressed,
and control groups. The authors concluded that pubertal timing
and psychological problems during adolescence might be related to
the age at onset of psychiatric disorders, and the association was
especially strong for BD (16).
Whether age at menarche has long-term effects on the course
of mental illnesses is even more obscure. A study on girls at age
24, followed up to 10 years, found that those reporting early
pubertal timing had greater risk of lifetime psychiatric disorders
compared to the on-time and late developers (17). Conversely, inFrontiers in Psychiatry | www.frontiersin.org 2a recent 3-year follow-up study among adolescent girls, the
relation between age at menarche and mental distress
disappeared among 15- to 18-year-old girls (18). To our
knowledge, today, there are no studies exploring the
relationship between age at menarche and long-term course of
BD. Furthermore, research is lacking on the correlation between
menarche time and medical diseases that commonly afflict
patients with BD such as metabolic syndrome whose
prevalence is higher than the general population. (19, 20).
Lastly, it is not known whether the risk of peripartum mood
episodes in women with BD may be influenced by the age at
menarche. Therefore, the aim of the present study is to analyze
the relationship between age at menarche and characteristics of
BD, including comorbid medical conditions and peripartum
mood episodes.METHODS
Sample
This is a cross-sectional observational study involving in- and
out-patients with diagnosis of BD consecutively referred to the
Psychiatric Unit of San Luigi Gonzaga University Hospital of
Orbassano (Turin, Italy), from January 2014 to June 2018. For the
purpose of the present study, only female subjects were considered.
Two hundred ninety-five women with BD were asked to
participate; five refused their consent. Among the 290 subjects
recruited, two (0.7%) were excluded from the research due to
lack of data on age at menarche. The analysis was performed on
288 women with BD I, II, or not otherwise specified (NOS)
according to the criteria of Diagnostic and Statistical Manual of
Mental Disorders–Fifth Edition (DSM-5) (21).
The study design was reviewed by the local ethics committee.
Written informed consent was obtained from participants after
the procedure had been fully explained.
Certified psychiatrists or residents in psychiatry supervised by
senior psychiatrists performed the clinical assessment of subjects.
Socio-demographic data (age, marital status, years of education,
and occupational status), clinical features of BD (age at onset and
other course specifiers such as type of bipolar cycle), and
comorbid psychiatric disorder were obtained through the
administration of a semi-structured interview that we developed
and used in regular clinical practice and in previous studies as well
(22). In addition, information on smoking and alcohol, medical
conditions (including metabolic syndrome), and reproductive cycle
event data were collected through individual patient medical
records. The metabolic syndrome was diagnosed in the patients
on the basis of the concurrent presence of at least three of the
following conditions: abdominal obesity, hypertriglyceridemia, low
HDL-cholesterol, high blood pressure, and high fasting glucose (23).Statistical Analysis
The study focused on two sets of comparisons, by age at
menarche and women with vs. without children (n = 288). Age
at menarche was both considered as a continuous variable andSeptember 2020 | Volume 11 | Article 00851
Rosso et al. Menarche Age and Bipolar Disordercategorized into three groups, defined according to previous
studies (24): early menarche (EM) (≤11 years), normal menarche
(NM) (12–14 years), and late menarche (LM) (≥15 years).
Spearman correlation matrix was produced to calculate
correlations between variables of interest. Socio-demographic and
clinical characteristics between EM, NM, and LM, and women with
vs. without children were examined through descriptive statistics.
Median (range) and frequencies (percentages) were used to
summarize the data on subject characteristics. Pearson chi-square
and Fisher Exact tests were used to examine the association between
categorical variables. Due to non-parametric nature of the data,
Kruskal-Wallis and Mann-Whitney were applied to test the
association between studied correlates. Bonferroni correction for
Kruskal-Wallis post-hoc multiple comparison testing was
performed. Further, the associations of age at menarche with
metabolic syndrome (controlling for age) and BD episodes in the
peripartum period (controlling for age, number of children, age at
onset of BD, type of BD and total number of affective episodes), as
well as the relationship between clinical characteristics and women
with children (controlling for age, age at onset of BD, and duration
of untreated illness) were examined through adjusted logistic
regression models. The potential confounding factors included in
the adjusted logistic regression models were selected according to
previous studies and clinical practice. The regression model on
woman with children was run for each clinical characteristic
separately. In case of collinearity (r ≥ 0.6), only one covariate was
chosen for the inclusion in the model. Missing data was <2.4% for
tested variables. Adjusted odds ratios (AOR), 95% confidence
intervals, and p-value of <.05 were estimated as the measures of
association. All statistical analyses were carried out using IBM SPSS
software version 25 (25).RESULTS
Age at Menarche
Results from Spearman correlations matrix are reported in Table
1. Significant positive correlations (p <.05) emerged between age
at menarche and number of lifetime depressive episodes (r =
0.118), duration of untreated illness (r = 0.155) and age at first
treatment for BD (r = 0.164) (Table 1). Out of 288 women with
BD included in the study, 21.5% had EM, 55.6% had NM, and
22.9% had LM. The median age of study participants and the
median age at menarche were, respectively, 51 (16–81) years and
13 (9–17) years (mean age at menarche 12.6 ± 1.3 years). About
58% of women had BD type II, the median age at the onset and
the median duration of BD were 27 (12–72) and 20 (0.1–57)
years, respectively. Adjusting for Bonferroni correction, women
with NM were younger than those with LM [47 (17–81) vs. 55
(32–75), p = .013], whereas women with EM had higher levels of
total cholesterol compared to those with NM [217 (125–377) vs.
193 (108–341), p = .024]. Moreover, women with EM had higher
proportion of metabolic syndrome compared to normal and LM
subgroups (41.7 vs. 24.2 vs. 28.1%, respectively, p = .039) (Table
2). After adjustment for age, EM was associated with 2 times
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Rosso et al. Menarche Age and Bipolar Disorder2.07; 95% CI, 1.07–3.99), whereas LM was not statistically
significant (Table 3).
Woman With and Without Children
Out of 288 women included in the study, 58.7% had children
(Table 4). Women with children had significantly higher
proportion of BD type II (65.7 vs. 47.9%, p = .008), lifetime
medical comorbidities (74.6 vs. 56.3%, p = .001), and metabolic
syndrome (37.0 vs. 17.2%, p = <.001), but lower lifetime
psychiatric comorbidities (30.8 vs. 51.3%, p<.001) compared to
women without children. Moreover, they were older [57 (27–81)
vs. 45 (16–81), p<.001], they had a later onset of BD [30 (14–72)
vs. 25 (12–68), p = .001] and a higher number of depressive [5 (0–
33) vs. 4 (0–20), p = .011] and hypomanic episodes [2 (0–33) vs.
1.5 (0–15), p = .014]. The duration of illness [23 (0.1–57) vs. 15 (1–
52), p<.001] and untreated illness [16 (0.1–51) vs. 7 (0.1–44),
p<.001] was also significantly higher for women with children
compared to woman without children. After controlling for
confounding factors, only lifetime psychiatric comorbidity
maintained its significance (OR: 0.56, 95% CI: 0.32–0.98) (Table
5). Out of 169 women with children, 29.6% had at least one BD
peripartum episode. The highest proportion of peripartum
episodes was observed in women with EM compared to women
with NM and LM (40.0 vs. 32.3 vs. 13.2%, p = .029) (Figure 1).
After adjustment, the LM was associated with lower probability of
BD episodes during the peripartum period compared to NM (OR:
0.33, 95% CI: 0.11–0.99) (Table 6).Frontiers in Psychiatry | www.frontiersin.org 4DISCUSSION
To our knowledge, this is the first study focusing on the association
between age at menarche and long-term course of illness in women
with BD. Given the known relationship between reproductive cycle
events andmood disorders, our hypothesis was that clinical features
of BD, and particularly the occurrence of perinatal mood episodes,
could be correlated with the timing of menarche.
The sample examined in our study was representative of the
population of women with BD: consistently with previous literature,
58.3% of women included in the study had BD type II, whereas the
median age of BD onset was 27 (12–72) (26, 27). Moreover, the
mean age at menarche (12.6 ± 1.3 years) was in line with the mean
age at menarche of general population (28–33). Spearman
correlations showed that age at menarche was positively associated
with the number of lifetime depressive episodes and the duration of
untreated illness. These findings are worthy of interest, but this is theTABLE 2 | Socio-demographic and clinical characteristics by age at menarche.
Characteristics Early menarche
(n = 62, 21.5%)
Normal menarche
(n = 160, 55.6%)
Late menarche




Age (year), median (range) 55 (16–80) 47 (17–81) 55 (32–75) 51 (16–81) 8.568 0.013c
Type of BD, n (%)
BD I 26 (41.9) 65 (40.6) 22 (33.3) 113 (39.2)
BD II 35 (56.5) 91 (56.9) 42 (63.6) 168 (58.3)
BD NOS 1 (1.6) 4 (2.5) 2 (3.0) 7 (2.4) 1.589 0.832b
Age at onset (year), median (range) 30 (12–60) 25 (14–72) 29 (14–69) 27 (12–72) 5.595 0.061c
Duration of illness (year), median (range) 21 (0.1–52) 17.5 (0.1–57) 23.5 (0.1–52) 20 (0.1–57) 4.662 0.097c
Duration of untreated illness (year), median (range) 8 (0.1–49) 11 (0.1–51) 14 (0.1–43) 12 (0.1–51) 5.394 0.067c
Lifetime total affective episodes, median (range) 7 (1–45) 8.5 (1–40) 8 (1–66) 8 (1–66) 4.683 0.096c
Lifetime major depressive episodes, median (range) 4 (0–25) 5 (0–30) 5 (0–33) 4 (0–33) 6.016 0.072
Lifetime hypomanic episodes, median (range) 1.5 (0–20) 2 (0–15) 2 (0–33) 2 (0–33) 1.014 0.602c
Lifetime psychiatric comorbidities, n (%)
No 41 (66.1) 91 (56.9) 43 (65.2) 175 (60.8)
Yes 21 (33.9) 69 (43.1) 23 (34.8) 113 (39.2) 2.296 0.317a
Lifetime medical comorbidities, n (%)
No 17 (27.4) 61 (38.1) 17 (25.8) 95 (33.0)
Yes 45 (72.6) 99 (61.9) 49 (74.2) 193 (67.0) 4.341 0.114a
Family history of BD, n (%)
No 43 (69.4) 123 (77.4) 50 (75.8) 216 (75.3)
Yes 19 (30.6) 36 (22.6) 16 (24.2) 71 (24.7) 1.546 0.462a
Metabolic syndrome, n (%)
No 35 (58.3) 119 (75.8) 46 (71.9) 200 (71.2)
Yes 25 (41.7) 38 (24.2) 18 (28.1) 81 (28.8) 6.472 0.039a
Total cholesterol (mg/dl), median (range) 217 (125–377) 193 (108–341) 207 (113–374) 199 (108–377) 8.292 0.024cSeptember 2020 | Volume 11 | ArticaPearson chi-square test.
bFisher Exact test performed.
cKruskal-Wallis test for non-parametric data (adjusted for Bonferroni correction).
Bold font indicates statistical significance.TABLE 3 | Age at menarche and metabolic syndrome.
CORa(95% CI) P-value AORb,c(95% CI) P-value
Age of menarche
Normal 1 1
Early 2.24 (1.19–4.20) 0.012 2.07 (1.07–3.99) 0.030
Late 1.23 (0.64–2.36) 0.544 1.01 (0.51–2.00) 0.969aCOR, crude odds ratios.
bAOR, adjusted odds ratios (adjusted for age).
cThe analytical sample included 281 subjects.le 00851
Rosso et al. Menarche Age and Bipolar Disorderfirst study to show this relationship and further methodologically
rigorous research is needed. The logistic regression showed that EM
was associated with the greater odds of metabolic syndrome, as
already observed in previous studies (34–38). The underlying
pathophysiological mechanisms involved in the association
between age at menarche and metabolic syndrome remain poorlyFrontiers in Psychiatry | www.frontiersin.org 5understood: whether EM functions as a risk factor by itself or via sex
hormones lifespan differences needs to be investigated. However, the
most suggested explanation is that EM in adolescent and metabolic
syndrome in adulthood is consequences of childhood obesity.
Childhood adiposity might trigger puberty by adipocytes and
related hormones (36). In addition, childhood obesity progresses
to adult obesity and is subsequently related withmetabolic syndrome
(39). Although more studies are needed to deepen the underlying
mechanisms, the association between age at menarche andmetabolic
disorders in women with BD should be taken into account when
choosing the pharmacological treatments.TABLE 4 | Differences in socio-demographic and clinical characteristics between women with and without children.
Characteristics Women with children
(n = 169, 58.7%)
Women without children
(n = 119, 41.3%)
X2/U test P-value
Age (year), median (range) 57 (27–81) 45 (16–81) 5346.5 <0.001c
Type of BD, n (%)
BD I 55 (32.5) 58 (48.7)
BD II 111 (65.7) 57 (47.9)
BD NOS 3 (1.8) 4 (3.4) 9.208 0.008b
Age at onset of BD (year), median (range) 30 (14–72) 25 (12–68) 7719.0 0.001c
Duration of illness (year), median (range) 23 (0.1–57) 15 (1–52) 7239.0 <0.001c
Duration of untreated illness (year), median (range) 16 (0.1–51) 7 (0.1–44) 6609.0 <0.001c
Lifetime total affective episodes, median (range) 8 (1–66) 7 (1–35) 9039.0 0.143c
Lifetime major depressive episodes, median (range) 5 (0–33) 4 (0–20) 8299.5 0.011c
Lifetime hypomanic episodes, median (range) 2 (0–33) 1.5 (0–15) 8362.5 0.014c
Lifetime psychiatric comorbidities, n (%)
No 117 (69.2) 58 (48.7)
Yes 52 (30.8) 61 (51.3) 12.298 <0.001a
Lifetime medical comorbidities, n (%)
No 43 (25.4) 52 (43.7)
Yes 126 (74.6) 67 (56.3) 10.526 0.001a
Family history of BD, n (%)
Metabolic syndrome, n (%)
No 104 (63.0) 96 (82.8)
Yes 61 (37.0) 20 (17.2) 12.922 <0.001a
Total Cholesterol (mg/dl), median (range) 209 (113–377) 188 (108–281) 5659.5 0.063September 2020 | Volume 11 | ArticaPearson chi-square test.
bFisher Exact test performed.
cMann-Whitney U test for non-parametric data.
Bold font indicates statistical significance.TABLE 5 | Clinical correlates of women with children.*
Characteristics COR (95% CI)a AOR (95%CI)b,c
Type of BD
BD I 1 1
BD II 2.05 (1.26–3.35) 1.59 (0.92–2.75)
BD NOS 0.79 (0.17–3.70) 1.06 (0.19–5.96)
Lifetime psychiatric comorbidities
No 1 1
Yes 0.42 (0.26–0.69) 0.56 (0.32–0.98)
Lifetime medical comorbidities
No 1 1
Yes 2.27 (1.38–3.75) 1.25 (0.70–2.22)
Metabolic syndrome
No 1 1
Yes 2.82 (1.58–5.01) 1.63 (0.86–3.11)
Lifetime major depressive episodes
(number)
1.07 (1.01–1.14) 1.04 (0.97–1.11)
Lifetime hypomanic episodes (number) 1.10 (1.02–1.19) 1.07 (0.98–1.17)*The regression models were run separately for each of the clinical characteristics
aCOR, crude odds ratios.
bAOR, adjusted odds ratios (adjusted for age, age at onset of BD, and duration of
untreated illness).
cThe analytical samples consist of 281 observations for all characteristics, except
metabolic syndrome (n = 274).
Bold font indicates statistical significance.FIGURE 1 | Differences in peripartum mood episodes between early, normal
and late menarche subgroups.le 00851
Rosso et al. Menarche Age and Bipolar DisorderIn order to examine the association between the age at
menarche and the occurrence of peripartum mood episodes, the
subgroup of women with children was analyzed (58.7% of the total
sample). They do not present significant clinical differences
compared to women without children except a lower rate of
psychiatric comorbidities. About one-third (29.6%) of them had
at least one mood episode with peripartum onset. The lack of data
on the pharmacological treatments at the time of pregnancy makes
it difficult to interpret this finding. However, the rate of
peripartum episodes in our study is slightly higher than those
found in samples of women taking medication during pregnancy
and much lower than those of women who were medication free
during pregnancy (40). In our sample, LM was associated with
lower probability of mood episodes with peripartum onset. Given
the lack of clinical predictors that may help to individualize the
risk of perinatal recurrence in women with BD (41), this result is
worthy of interest and deserves to be deepened in further studies.
The results should be considered in light of several limitations.
First, the cross-sectional design of the study does not allow to infer
causal relationship between studied variables. Although we can
eliminate the risk of reverse bias for some characteristics such as
age at menarche, the temporal order for other characteristics
remains an unsolved problem. Moreover, there may be some
unmeasured confounders such as medications we could not
control for in our model: Variables such as age, duration of
illness, and number of lifetime mood episodes could lead to
different types of pharmacological treatments interfering with
associations reported in the study. Finally, significant associations
may have been lost for some variables due to the sample size.
However, there are also few strengths: The missing data for studied
variables was very low, models were adjusted for several
confounders, and data allowed us to examine the associations
with a large number of clinical characteristics.Frontiers in Psychiatry | www.frontiersin.org 6CONCLUSION
The results suggest that age at menarche may be associated with
specific characteristics of women with BD: EM with higher
probability of developing metabolic syndrome and LM with
lower rate of peripartum mood episode. If confirmed by
further studies, these findings might improve the ability to
predict long-term BD outcomes and to choose tailored
treatments for specific subgroups of patients.DATA AVAILABILITY STATEMENT
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